Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection

Date
2017
Author
Gumus, Mahmut
Ciltas, Aydin
Ustaalioglu, Basak Bala
Uysal, Mukremin
Esbag, Onur
Yazilitas, Dogan
Tanriverdi, Ozgur
Bilici, Ahmet
Arpaci, Erkan
Berk, Veli
Yetisyigit, Tarkan
Ozdemir, Nuriye Yildirim
Oztop, Ilhan
Alacacioglu, Ahmet
Aydin, Ozhan
Ozcelik, Melike
Yildirim, Emre
KEFELİ, UMUT
Unal, Olcun Umit
Tastekin, Didem
Akyol, Murat
Dinc, Nur
Tanrikulu, Eda
Aydin, Dincer
Sendur, Mehmet Ali
Metadata
Show full item record
Abstract
This is a multicenter study to assess the prognostic factors and adjuvant chemotherapy in patients with small bowel adenocarcinoma (SBA). A total of 78 patients with SBA diagnosed with completely resected SBA were involved in the study. Only status of surgical margin was determined to be an independent prognostic factor in patients with SBA who underwent curative resection. Neither disease-free survival nor overall survival was found to be significantly improved by the adjuvant chemotherapy
URI
http://hdl.handle.net/20.500.12627/76659
https://doi.org/10.1016/j.clcc.2016.08.002
Collections